0/100 · Low Risk
Manufactured by CVS Pharmacy
No Adverse Events Reported for Benzoic Acid
Last updated: 2026-05-12
BENZOCAINE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by CVS Pharmacy. Based on analysis of FDA adverse event reports, BENZOCAINE has a safety score of 0 out of 100. This lower score reflects a significant number of adverse event reports, suggesting that patients should discuss potential risks carefully with their healthcare provider. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for BENZOCAINE.
Benzocaine has a safety concern score of 0 out of 100, placing it in the low concern category based on analysis of FDA adverse event data. The FDA has received approximately N/A adverse event reports for this medication, which is primarily manufactured by Cvs Pharmacy.
No serious or non-serious adverse events reported for Benzoic Acid.
The data shows a balanced distribution of reports across different ages and sexes. No significant trends or patterns in adverse events were observed.
Patients taking Benzocaine should monitor for the commonly reported side effects and contact their healthcare provider if they experience any unusual symptoms. This analysis is based on voluntary FDA adverse event reports and should not replace professional medical advice.
Benzocaine received a safety concern score of 0/100 (low concern). The score accounts for N/A total adverse event reports and 0 distinct reaction types. This relatively low score suggests a favorable safety profile in reported data.
Adverse event reports by sex: Female: 568, Male: 328, Unknown: 8. The most frequently reported age groups are age 43 (34 reports), age 54 (23 reports), age 25 (20 reports). These demographics reflect reporting patterns and may not represent the full patient population.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
If you are taking Benzocaine, here are important things to know. No specific precautions or warnings are necessary based on the current data. Continue to follow the prescribed usage and dosing instructions. If you experience a serious adverse reaction, seek emergency medical attention immediately or call 911. You can report side effects to the FDA's MedWatch program at 1-800-FDA-1088.
The FDA has received approximately N/A adverse event reports associated with Benzocaine. These reports come from healthcare professionals, consumers, and manufacturers through the FDA Adverse Event Reporting System (FAERS). Note that the number of reports does not directly indicate the frequency of side effects, as adverse events are voluntarily reported and may be underrepresented.
Adverse event reports for Benzocaine break down by patient sex as follows: Female: 568, Male: 328, Unknown: 8. This distribution reflects reporting patterns rather than actual risk differences between groups. Reporting rates can be influenced by prescribing patterns, disease demographics, and reporting behavior.
The most frequently reported age groups for Benzocaine adverse events are: age 43: 34 reports, age 54: 23 reports, age 25: 20 reports, age 61: 20 reports, age 65: 18 reports. Age-related reporting patterns can reflect both the demographics of the patient population and potential age-related susceptibility to certain side effects.
The primary manufacturer associated with Benzocaine adverse event reports is Cvs Pharmacy. Multiple manufacturers may produce generic versions of this drug. The manufacturer listed reflects the most frequently reported brand in FDA adverse event data.
You can report adverse events from Benzocaine to the FDA through their MedWatch program at www.fda.gov/medwatch, by calling 1-800-FDA-1088, or by completing Form FDA 3500. Healthcare professionals, consumers, and manufacturers can all submit reports. Reporting helps the FDA monitor drug safety after approval.
Benzocaine has a safety concern score of 0 out of 100 (low concern). This score is calculated from the ratio of serious to non-serious adverse events, the diversity of reported reactions, and the overall volume of reports relative to usage. No serious or non-serious adverse events reported for Benzoic Acid.
Key safety signals identified in Benzocaine's adverse event data include: No serious adverse events reported.. No non-serious adverse events reported.. No adverse events reported across different age groups.. These signals are derived from patterns in FDA reports and should be discussed with a healthcare provider for personalized assessment.
No specific precautions or warnings are necessary based on the current data. Continue to follow the prescribed usage and dosing instructions.
Benzocaine has N/A adverse event reports on file with the FDA. The data shows a balanced distribution of reports across different ages and sexes. The volume of reports for Benzocaine reflects both the drug's usage level and the vigilance of the reporting community.
Explore other medications manufactured by CVS Pharmacy and compare their safety profiles: